Antioxidant supplementation and cancer patients receiving curative-intent chemotherapy

Smith, Peter J; Steadman, Kathryn J

doi:10.5694/mja15.01196

Topics

Much of the advice in the lay press regarding the benefits of antioxidants for people undergoing cancer treatment does not qualify or differentiate between curative and palliative cancer treatment or the type of cancer treatment involved.

1 Sunshine Coast Cancer Care Services, Nambour General Hospital, Nambour, QLD
2 University of Queensland, Brisbane, QLD

Correspondence: peter.smith@health.qld.gov.au

Competing interests:

No relevant disclosures.

1. Gianni AM, Piccart MJ. Optimising chemotherapy dose density and dose intensity. Eur J Cancer 2000; 36 Suppl 1: S1-3.
2. Hudis C, Dang C. The development of dose-dense adjuvant chemotherapy. Breast J 2015; 21: 42-51.
3. Lawenda BD, Kelly KM, Ladas EJ, et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008; 100: 773-783.
4. D’Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005; 55: 319-321.
5. Block KI, Koch AC, Mead MN, et al. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007; 33: 407-418.
6. Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther 2016; 15: 17-39.

Online responses are no longer available. Please refer to our instructions for authors page for more information.